On clinical application, the HLA (Human leukocyte antigen) compatibility, viability and quantity of stem cells in the cord blood sample is crucial to a successful transplant.
To ensure the cord blood sample is in its best quality for future use, we have upgraded our system in cord blood collection, processing and storage. In 2008, CRYOLIFE was the first in Hong Kong to migrate to automated processing with the adoption of the AXP AutoXpress™ Platform.
In storage, we have adopted the more advance vapour phase liquid nitrogen storage tanks which eliminates the risk of virus transfer and cross contamination.
